ID: MRFR/HC/0620-HCRR | February, 2018 | Region: Global | 200 pages | Half-Cooked Research Reports
Global Blood Transfusion Diagnostics Market Information by Type (Instruments, Reagents), By Application (Blood Grouping, disease Screening), By End users (Hospital, laboratories, Blood Banks, Plasma Fractionation Facilities) - Forecast to 2027
Study Objectives of Blood Transfusion Diagnostics
Market Synopsis of Blood Transfusion Diagnostics
Globally the market for Blood Transfusion Diagnostics is increasing rapidly mainly due to increasing transfusion safety. The factors that influence the growth of blood transfusion diagnostics market; increasing safety with nucleic acid testing, blood testing products, immunoassay reagents that recognize irresistible infection, safety in blood preservations, pre-typing of blood donors and others.
Globally the market for blood transfusion diagnostics is expected to grow at the rate of about XX% CAGR from 2016 to 2027.
The market for Blood Transfusion Diagnostics is segmented into mainly three; by type, by application and by End users and its various sub-segments. By type include Instruments, Reagents, Others. Whereas by application it includes Blood Grouping, disease Screening, others. Furthermore by end users include Hospital, laboratories, Blood Banks, Plasma Fractionation Facilities, Military Blood Banks and others.
Regional Analysis of Blood Transfusion Diagnostics
North America dominated the global blood transfusion diagnostics market with the largest market share, accounting for $XX million and is expected to grow over $XX billion by 2027. The European market for blood transfusion diagnostics is expected to grow at XX% GAGR (2016-2027). Asia-Pacific is expected to grow at CAGR of XX% from $ XX million in 2016 to $XX million by 2027.
The key players that are involved in global blood transfusion diagnostics market are Immucor (U.S), Ortho Clinical Diagnostics (U.S), Beckman Coulter (U.S), Quotient Limited (U.S), Diagast (France), Abbott Diagnostics (U.S), Novartis AG (Switzerland), Becton Dickinson (U.S), BAG healthcare (Germany) DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Siemens (Germany), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain), Bio-Rad (U.S).
The Middle East & Africa
The report for Blood Transfusion Diagnostics of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.